Vancomycin dosing in an obese patient with acute renal failure: A case report and review of literature

BACKGROUND: Vancomycin is the most commonly used drug for methicillin-resistant Staphylococcus aureus. The empirical clinical doses of vancomycin based on non-obese patients may not be optimal for obese ones. CASE SUMMARY: This study reports a case of vancomycin dosing adjustment in an obese patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Kun-Yan, Li, Dan, Hu, Zhen-Jie, Zhao, Cong-Cong, Bai, Jing, Du, Wen-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254177/
https://www.ncbi.nlm.nih.gov/pubmed/35949852
http://dx.doi.org/10.12998/wjcc.v10.i18.6218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254177/
https://www.ncbi.nlm.nih.gov/pubmed/35949852
http://dx.doi.org/10.12998/wjcc.v10.i18.6218

Ejemplares similares